Gyre Therapeutics
San Diego, US
Biotech
Founders & leadership
HY
Han YingDirector
UN
Usman NassimDirector
WY
Weiguo YuExecutive Officer
RP
Renate ParryDirector
YL
Ying LuoDirector
SM
Songjiang MaDirector, Executive Officer
TE
Thomas EastlingDirector
GG
Gordon G. CarmichaelDirector
RC
Ruoyu ChenExecutive Officer
CW
Charles WuDirector, Executive Officer
Reported raises · per SEC filings
Form D private placements▶$5MraisedNov 2023 · 1 investors · PharmaceuticalsRule 506(b)
▶$5MraisedNov 2023 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Han YingDirector
- Usman NassimDirector
- Weiguo YuExecutive Officer
- Renate ParryDirector
- Ying LuoDirector
- Songjiang MaDirector, Executive Officer
- Thomas EastlingDirector
- Gordon G. CarmichaelDirector
- Ruoyu ChenExecutive Officer
- Charles WuDirector, Executive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.